BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Oct 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-10-17

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-17	Common Stock	M	41666	$17.54	Acquired	365034	Direct
2016-10-17	Common Stock	S	41666	$84.3908	Disposed	323368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-17	Stock Option (right to buy Common Stock)	$17.54	M	41666	Disposed	2016-11-19	Common Stock (41666)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25758	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on August 17, 2015. Mr. Bienaime's former spouse will receive approximately 17% of the net proceeds from the shares sold in this transaction pursuant to a martial separation agreement between her and Mr. Bienaime.

F2: The price in column 4 is the weighted average price. The price actually received ranged from $82.365 to $85.42. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.